Skip to main content
SpringerLink
Log in

A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury

Gene atlas array analysis

  • Peptide Drug Design, Pharmacology, And Delivery In Health And Disease
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The femtomolar-acting eight-amino-acid peptide (NAP), derived from activity-dependent neuroprotective protein (ADNP), provides long-term protection against the deleterious effects of closed head injury (CHI) in mice. Fifteen minutes after injury, mice were divided into two groups, control and NAP-treated and a single subcutaneous injection of NAP or vehicle was administered. A third group served as sham-treated (not subjected to head trauma). Each mouse was assessed for its clinical function, using neurological severity score, at various time intervals following CHI, up to 30–45 d. Total cerebral cortex RNA was prepared from the site of injury of CHI mice, and from parallel regions in peptide-treated and sham brains. RNA was then reversed transcribed to yield radioactive cDNA preparations that were hybridized to Atlas array membranes containing 1200 cDNAs spots. Comparison of sham-treated individual mice showed differential expression levels of at least 15 mRNA species. Furthermore, results indicated that one of the genes that did not change among individuals but specifically increased after CHI and decreased after NAP treatment was the cell surface glycoprotein Mac-1 (CD11B antigen). Thus, Mac-1 is suggested as a marker for the long-term outcome of head injury and as a potential target for NAP protective actions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arnaout M. A., Todd R. F., Dana N., Melamed J., Schlossman S. F., and Colten H. R. (1983) Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J. Clin. Invest. 72, 171–179.

    Article  PubMed  CAS  Google Scholar 

  • Arvin B., Neville L. F., Barone F. C., and Feuerstein G. Z. (1995) Brain injury and inflammation. A putative role of TNF alpha. Ann. N.Y. Acad. Sci. 15, 62–71; discussion 98–99.

    Article  Google Scholar 

  • Bassan M., Zamostiano R., Davidson A., et al. (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283–1293.

    Article  PubMed  CAS  Google Scholar 

  • Beni-Adani L., Gozes I., Cohen Y., et al. (2001) A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57–63.

    PubMed  CAS  Google Scholar 

  • Bell M. J., Kochanek P. M., Doughty L. A., et al. (1997) Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 14, 451–457.

    PubMed  CAS  Google Scholar 

  • Brenneman D. E. and Eiden L. E. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83, 1159–1162.

    Article  PubMed  CAS  Google Scholar 

  • Chen Y., Constantini S., Trembovler V., Weinstock M., and Shohami E. (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J. Neurotrauma. 13, 557–568.

    PubMed  CAS  Google Scholar 

  • Chopp M., Zhang R. L., and Chen H. (1994) Postischemic administration of anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25, 869–875; discussion 875–866.

    PubMed  CAS  Google Scholar 

  • Chopp M., Li Y., and Jiang N. (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle serebral artery occlusion in rat brain. J. Cereb. Blood Flow Metab. 16, 578–584.

    Article  PubMed  CAS  Google Scholar 

  • Coria F., Rubio I., and Bayon C. (1994) Alzheimer’s disease, beta-amyloidosis, and aging. Rev. Neurosci. 5, 275–292.

    PubMed  CAS  Google Scholar 

  • Diamond M. S., Garcia-Aguilar J., Bickford J. K., Corbi A. L., and Springer T. A. (1993) The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031–1043.

    Article  PubMed  CAS  Google Scholar 

  • Engel S., Wehner H. D., and Meyermann R. (1996) Expression of microglial markers in the human CNS after closed head injury. Acta. Neurochir. Suppl. (Wien.) 66, 89–95.

    CAS  Google Scholar 

  • Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D. H., and McIntosh T. K. (1996) Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Mol. Brain Res. 36, 287–291.

    Article  PubMed  CAS  Google Scholar 

  • Feuerstein G.Z., Wang X., and Barone F.C. (1997) Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann. N.Y. Acad. Sci. 15, 179–193.

    Article  Google Scholar 

  • Gedye A., Beattie B. L., Tuokko H., Horton A., and Korsarek E. (1989) Severe head injury hastens age of onset of Alzheimer’s disease. J. Am. Geriatr. Soc. 37, 970–973.

    PubMed  CAS  Google Scholar 

  • Gozes I. and Brenneman D. E. (1989) VIP: molecular biology and neurobiological function. Mol. Neurobiol. 3, 201–236.

    PubMed  CAS  Google Scholar 

  • Gozes I., Fridkin M., Hill J. M., and Brenneman D. E. (1999) Pharmaceutical VIP: prospects and problems. Curr. Med. Chem. 6, 1019–1034.

    PubMed  CAS  Google Scholar 

  • Gozes I., Giladi E., Pinhasov A., Bardea A., and Brenneman D. E. (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a watermaze. J. Pharmacol. Exp. Therap. 293, 1091–1098.

    CAS  Google Scholar 

  • Holmin S. and Mathiesen T. (1999) Long-term intracerebral inflammatory response after experimental focal brain injury in rat. Neuroreport. 10, 1889–1891.

    Article  PubMed  CAS  Google Scholar 

  • Hoshino S., Tamaoka A., Takahashi M., et al. (1998) Emergence of immunoreactivities for phosphorylated tau and amyloid-beta protein in chronic stage of fluid percussion injury in rat brain. Neuroreport. 9, 1879–1883.

    Article  PubMed  CAS  Google Scholar 

  • Kita T., Liu L., Tanaka N., and Kinoshita Y. (1997) The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. Intl. J. Legal Med. 110, 305–311.

    Article  CAS  Google Scholar 

  • Kochanek P. M. and Hallenbeck J. M. (1992) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23, 1367–1379.

    PubMed  CAS  Google Scholar 

  • Kossmann T., Hans V., Imhof H. G., Trentz O., and Morganti-Kossmann M.C. (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713, 143–152.

    Article  PubMed  CAS  Google Scholar 

  • Matsuo Y., Kihara T., and Ikeda M. (1995) Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: affect of neutrophil depletion on extracellular ascorbyl radical formation. J. Cereb. Flow. Metab. 15, 941–947.

    CAS  Google Scholar 

  • McIntosh T. K., Juhler M., and Wieloch T. (1998) Novel pharmacologic strategies in the treatment of experimental traumatic brain injury. J. Neurotrauma 15, 731–769.

    PubMed  CAS  Google Scholar 

  • Morganti-Kossmann M. C., Lenzlinger P. M., Hans V., et al. (1997) Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry 2, 133–136.

    Article  Google Scholar 

  • Nonaka M., Chen X. H., Pierce J. E., et al. (1999) Prolonged activation of NF-kappaB following traumatic brain injury in rats. J. Neurotrauma 16, 1023–1034.

    Article  PubMed  CAS  Google Scholar 

  • Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D. E., and Gozes I. (2000) Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson’s disease. Brain Res. 854, 257–262.

    Article  PubMed  CAS  Google Scholar 

  • Scherbel U., Raghupathi R., Nakamura M., et al. (1999) Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. USA 96, 8721–8726

    Article  PubMed  CAS  Google Scholar 

  • Shohami E., Novikov M., Bass R., Yamin A., and Gallily R. (1994) Closed head injury triggers early production of TNFα and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14, 615–619.

    PubMed  CAS  Google Scholar 

  • Shohami E., Gallily R., Mechoulam R., Bass R., and Ben-Hur T. (1997) Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J. Neuroimmunol. 72, 169–177.

    Article  PubMed  CAS  Google Scholar 

  • Stahel P.F., Kariya K., Shohami E., Barnum S. R., Eugster H. P., Trentz O., Kossmann T., and Morganti-Kossmann M. C. (2000) Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphtoxin-α following closed head injury in mice. J. Neuroimmunol. 109, 164–172.

    Article  PubMed  CAS  Google Scholar 

  • Stahel P. F., Shohami E., Younis F. M., et al. (2000) Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20, 369–380.

    Article  PubMed  CAS  Google Scholar 

  • Steingart R. A., Solomon B., Brenneman D. E., Fridkin M., and Gozes I. (2000) VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 15, 137–145.

    Article  PubMed  CAS  Google Scholar 

  • Taupin V., Toulmond S., Serrano A., Benavides J., and Zavala F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177–185.

    Article  PubMed  CAS  Google Scholar 

  • Walzog B., Weinmann P., Jeblonski F., Scharffetter-Kochanek K., Bommert K., and Gaehtgens P. (1999) A role for beta (2) integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response. FASEB J. 13, 1855–1865.

    PubMed  CAS  Google Scholar 

  • Whalen M. J., Carlos T. M., and Adelson P. D. (1998) Intreleukin-8 is in creased in CSF of children with severe traumatic brain injury. Crit. Care Med. 26, A85.

    Google Scholar 

  • Whalen M. J., Carlos T. M., Clark R. S., and Kochanek P. M. (1999) An acute inflammatory response to the use of granulocyte colony-stimulating factor to prevent infections in patients with brain injury: what about the brain? Crit. Care Med. 27, 1014–1018.

    Article  PubMed  CAS  Google Scholar 

  • Wright S. D., Rao P. E., Van Voorhis W. C., et al. (1983) Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80, 5699–5703.

    Article  PubMed  CAS  Google Scholar 

  • Zamostiano R., Pinhasov A., Gelber E., et al. (2001) Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276, 708–714.

    Article  PubMed  CAS  Google Scholar 

  • Zemlyak I., Furman S., Brenneman D. E., and Gozes I. (2000) A novel peptide (NAP) prevents death in enriched neuronal cultures. Regulatory Peptides 96, 39–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978, Tel Aviv, Israel

    Jacob Romano & Illana Gozes

  2. Sourasky Medical Center, Tel Aviv University, USA

    Liana Beni-Adani

  3. Life Science, Tel Aviv University, 20892, Bethesda, MD, USA

    Orlev Levy Nissenbaum

  4. Section on Developmental and Molecular Pharmacology, LDN, NICHD, NIH, 20892, Bethesda, MD, USA

    Douglas E. Brenneman

  5. Pharmacology, The Hebrew University School of Pharmacy, 91120, Jerusalem, Israel

    Esther Shohami

Authors
  1. Jacob Romano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liana Beni-Adani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orlev Levy Nissenbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Douglas E. Brenneman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Esther Shohami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Illana Gozes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Illana Gozes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romano, J., Beni-Adani, L., Nissenbaum, O.L. et al. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury. J Mol Neurosci 18, 37–45 (2002). https://doi.org/10.1385/JMN:18:1-2:37

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:18:1-2:37

Index Entries

Search

Navigation